Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HUDSON TECHNOLOGIES INC /NYHDSN · Entity 6244 | VP Sales | December 19, 2017 | December 21, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HUDSON TECHNOLOGIES INC /NY
Report date December 19, 2017 · Filed December 21, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.70 · Expires 2020-12-19 | Direct | 0 |
Reported balance
After 2017-12-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-12-19 · Grant · Acquired 158,645 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 19, 2017 Filed Dec 21, 2017 22:07 UTC | HUDSON TECHNOLOGIES INC /NY HDSN · Entity 6244 | GrantStock Option (Right to Buy) · Derivative | 158,645 | $0.00 Strike: $5.70 | $0.00 |
DisclosureSEC source: 0001010541-17-000027 · primary_doc.xml · derivative · entry 1 HARKINS CHARLES F · CIK 0001250707 · VP Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 158,645 shares Expires 2020-12-19 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.